Search

Illumina Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

190.68 -0.73

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

186.22

Max

193.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-268M

-134M

Pardavimai

68M

1.2B

P/E

Sektoriaus vid.

35.062

57.002

Pelnas, tenkantis vienai akcijai

1.31

Pelno marža

-11.562

Darbuotojai

8,600

EBITDA

80M

330M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+1.19% upside

Dividendai

By Acuity

Kitas uždarbis

2026-10-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

293M

29B

Ankstesnė atidarymo kaina

191.41

Ankstesnė uždarymo kaina

190.68

Naujienos nuotaikos

By Acuity

50%

50%

171 / 340 reitingas Healthcare

Illumina Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-13 20:06; UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

2026-08-12 22:02; UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

2026-08-11 19:16; UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

2026-08-10 23:16; UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

2026-08-07 19:46; UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

2026-08-06 23:06; UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

2026-08-05 19:52; UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

2026-08-04 19:31; UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

2026-08-03 20:03; UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

2026-07-31 23:06; UTC

News

Illumina Inc reported strong Q2 results and raised full-year guidance, yet shares declined in after-market trading from Friday's close of $202.95.

2026-07-30 23:41; UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

2026-07-29 23:26; UTC

Illumina Inc. shares declined after-market amid overall market volatility following the Federal Reserve's decision to maintain interest rates amid rising inflation concerns.

2026-07-28 19:46; UTC

News

Illumina Inc. is acquiring contingent payments from its merger with Treeline Biosciences to enhance integration. Shares are trading higher since Monday's close.

2026-07-27 23:26; UTC

Illumina Inc shares are lower in after-market hours, continuing a decline over the past three sessions with no specific news identified.

2026-07-24 17:46; UTC

Illumina Inc's shares are lower today, hitting a mid-morning low. Broader market sentiment may be affected by recent volatility in oil prices.

2026-07-22 19:31; UTC

News

Illumina Inc shares are lower amid a report citing stagnant sales and concerns over management's investment opportunities. The company may need acquisitions for growth.

2026-07-21 20:02; UTC

Correlated Moves
News

Illumina Inc's shares are higher, supported by broader market momentum and anticipation of upcoming earnings from major companies. The Russell 2000 Index also advanced.

2026-07-20 19:56; UTC

Correlated Moves

Illumina Inc shares declined during Monday's session, paralleling a drop in the ARK Genomic Revolution ETF amid broader market weakness.

2026-07-17 19:06; UTC

Illumina Inc shares are lower today amid broader market declines, particularly in technology and semiconductor stocks, following significant selling pressure in Asia.

2026-07-16 22:06; UTC

Illumina Inc shares are lower in after-market hours, tracking broader market declines amid geopolitical tensions and mixed economic indicators.

2026-07-15 18:51; UTC

Illumina Inc shares declined Wednesday, pulling back from earlier gains. No specific news was identified to explain this movement amid broader positive market trends.

2026-07-14 19:36; UTC

News

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

2026-07-10 20:06; UTC

Correlated Moves

Illumina Inc shares are lower amid a broader decline in the biotechnology sector. Market volatility is heightened due to geopolitical tensions involving the U.S. and Iran.

2026-07-09 19:11; UTC

News
Correlated Moves

Illumina Inc. appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, contributing to a rise in shares amid sector gains.

2026-07-08 20:04; UTC

Correlated Moves

Illumina Inc shares are lower today, influenced by declines in the Life Sciences Tools & Services sector and a drop in the Russell 2000 Index.

2026-07-07 21:41; UTC

Illumina Inc. shares are higher in after-market trading, reflecting ongoing strength despite earlier session pullbacks and broader caution in the technology sector.

2026-07-06 19:52; UTC

Social Media
News

Evercore ISI raised its price target on Illumina to $200, maintaining an Outperform rating. Shares are trading higher amid positive sentiment and social media discussions.

2026-07-02 23:06; UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader trends despite positive movements in European equity indices, including a rise in the DAX.

2026-07-01 20:03; UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

2026-06-30 20:01; UTC

News
Social Media

Illumina Inc shares are lower as Roche launches a competing gene sequencer at a lower price, challenging Illumina's market share in genetic testing technology.

Akcijų palyginimas

Kainos pokytis

Illumina Inc Prognozė

Kainos tikslas

By TipRanks

1.19% į viršų

12 mėnesių prognozė

Vidutinis 194.93 USD  1.19%

Aukščiausias 230 USD

Žemiausias 113 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Illumina Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

15 ratings

7

Pirkti

5

Laikyti

3

Parduoti

Rinkos nuotaikos

By Acuity

171 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat